Home › Compare › IBXXF vs STAG

IBXXF vs STAG: Dividend Comparison 2026

IBXXF yields 17857.14% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBXXF wins by $17047106584171659264.00M in total portfolio value
10 years
IBXXF
IBXXF
● Live price
17857.14%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17047106584171659264.00M
Annual income
$16,861,361,028,467,424,000,000,000.00
Full IBXXF calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.06
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.70
Full STAG calculator →

Portfolio growth — IBXXF vs STAG

📍 IBXXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBXXFSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBXXF + STAG cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IBXXF pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBXXF
Annual income on $10K today (after 15% tax)
$1,517,857.14/yr
After 10yr DRIP, annual income (after tax)
$14,332,156,874,197,310,000,000,000.00/yr
STAG
Annual income on $10K today (after 15% tax)
$292.69/yr
After 10yr DRIP, annual income (after tax)
$393.29/yr
At 15% tax rate, IBXXF beats the other by $14,332,156,874,197,310,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBXXF + STAG for your $10,000?

IBXXF: 50%STAG: 50%
100% STAG50/50100% IBXXF
Portfolio after 10yr
$8523553292085829632.00M
Annual income
$8,430,680,514,233,712,000,000,000.00/yr
Blended yield
98.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

IBXXF
No analyst data
Altman Z
-55.2
Piotroski
4/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.8% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBXXF buys
0
STAG buys
0
No recent congressional trades found for IBXXF or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBXXFSTAG
Forward yield17857.14% ✓3.44%
Annual dividend / share$2.00 ✓$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3% ✓
Portfolio after 10y$17047106584171659264.00M ✓$18.3K
Annual income after 10y$16,861,361,028,467,424,000,000,000.00 ✓$462.70
Total dividends collected$17034838237245739008.00M ✓$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: IBXXF vs STAG ($10,000, DRIP)

YearIBXXF PortfolioIBXXF Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$1,796,414$1,785,714.29$10,665$345.38+$1.79M → IBXXF
2$301,724,280$299,802,117.11$11,365$358.01+$301.71M → IBXXF
3$47,383,143,508$47,060,298,527.98$12,099$370.76+$47383.13M → IBXXF
4$6,957,621,293,196$6,906,921,329,642.40$12,870$383.63+$6957621.28M → IBXXF
5$955,290,364,037,133$947,845,709,253,412.80$13,678$396.60+$955290364.02M → IBXXF
6$122,648,736,931,019,340$121,626,576,241,499,600.00$14,526$409.67+$122648736931.00M → IBXXF
7$14,725,168,454,748,666,000$14,593,934,306,232,474,000.00$15,413$422.82+$14725168454748.65M → IBXXF
8$1,653,272,868,532,626,000,000$1,637,516,938,286,045,300,000.00$16,343$436.05+$1653272868532626.25M → IBXXF
9$173,593,977,293,677,440,000,000$171,824,975,324,347,530,000,000.00$17,315$449.35+$173593977293677440.00M → IBXXF
10$17,047,106,584,171,660,000,000,000$16,861,361,028,467,424,000,000,000.00$18,332$462.70+$17047106584171659264.00M → IBXXF

IBXXF vs STAG: Complete Analysis 2026

IBXXF — Stock

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.

Full IBXXF Calculator →

STAG — REIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this IBXXF vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBXXF vs SCHDIBXXF vs JEPIIBXXF vs OIBXXF vs KOIBXXF vs MAINIBXXF vs PLDIBXXF vs EQRIBXXF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.